Ngā hua rapu - Robert Hettle
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
Systematic literature review and network meta-analysis of cladribine tablets versus alternative disease-modifying treatments for relapsing–remitting multiple sclerosis mā Mohd Kashif Siddiqui, Ishant Khurana, S Budhia, Robert Hettle, Gerard Harty, Schiffon L. Wong
I whakaputaina 2017Revisão -
2
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal mā Robert Hettle, Mark Corbett, Sebastian Hinde, Robert Hodgson, Julie Jones-Diette, Nerys Woolacott, Stephen Palmer
I whakaputaina 2017Artigo -
3
Cost-Effectiveness of Adding Bedaquiline to Drug Regimens for the Treatment of Multidrug-Resistant Tuberculosis in the UK mā Lara J. Wolfson, Anna N. Walker, Robert Hettle, Xiaoyan Lu, Chrispin Kambili, A. Murungi, Gerhart Knerer
I whakaputaina 2015Artigo -
4
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial mā Mark E. Robson, Kathryn J. Ruddy, Seock‐Ah Im, Elżbieta Senkus, Binghe Xu, Susan M. Domchek, Norikazu Masuda, Wei Li, Nadine Tung, Anne Armstrong, Suzette Delaloge, Wendy Bannister, Carsten Goessl, Arnold Degboe, Robert Hettle, Pierfranco Conté
I whakaputaina 2019Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Pathology
Alternative medicine
Biology
Economic evaluation
Genetics
Accounting
Adverse effect
Alemtuzumab
BRCA mutation
Bedaquiline
Breast cancer
Business
Cancer
Cell
Chemotherapy
Cladribine
Cochrane Library
Cohort
Confidence interval
Cost effectiveness
Cost-effectiveness analysis
Critical appraisal
Culture conversion
Economic appraisal
Economics
Eribulin
Fingolimod
Gene